SRES-499-119
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S8207)
Sponsored by Jon Husted (R-OH)
What it does
This resolution would express the Senate's support for the goals and ideals of "Creutzfeldt-Jakob Disease (CJD) Awareness Day," designated as November 12, 2025. It would formally recognize the importance of raising public awareness about CJD, a rare and fatal prion brain disorder. The resolution carries no binding legal force, creates no new programs, and appropriates no funds.
Who benefits
Patients diagnosed with CJD and their families, who may gain broader public recognition of the disease's severity and rapid progression. Caregivers of CJD patients, who face unique burdens due to the disease's rapid course. Researchers studying prion diseases, who may benefit from increased public and legislative attention. The National Prion Disease Pathology Surveillance Center, the only U.S. laboratory monitoring human prion diseases, which could gain visibility. Alzheimer's and dementia researchers, whose work the resolution notes may benefit from prion disease study. Hunters and rural communities concerned about chronic wasting disease (CWD) in deer, elk, and moose populations across 36+ states.
Who is hurt
No group is directly harmed by this resolution. As a purely symbolic measure, it imposes no costs, mandates, or restrictions on any individual, organization, or government entity.
Supporters argue
Supporters argue that CJD affects approximately 600 Americans annually and is responsible for 1 in every 6,000 U.S. deaths, yet remains largely unknown to the public and underrepresented in research funding conversations. They contend that formal Senate recognition raises the profile of the only U.S. prion surveillance laboratory and draws attention to the potential public health risk of chronic wasting disease spreading to humans — a concern documented in cervids across all four U.S. regions and more than 36 states.
Opponents argue
Opponents argue that symbolic resolutions consume limited Senate floor and committee time without producing measurable policy outcomes, and that awareness alone does not fund research, expand surveillance capacity, or address the potential CWD-to-human transmission risk highlighted in the resolution's own text. They contend that if CJD and prion disease surveillance are genuine public health priorities, the appropriate legislative response would be direct appropriations or a mandate to expand the National Prion Disease Pathology Surveillance Center's capacity — not a non-binding declaration.